{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:19:21Z","timestamp":1786987161990,"version":"build-2736575974"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100030860","name":"Mawlana Bhashani Science and Technology University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030860","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.compbiomed.2025.110867","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T10:47:40Z","timestamp":1754304460000},"page":"110867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PB","title":["Targeting MMP-7 in idiopathic pulmonary fibrosis: An integrative in vivo and in silico evaluation of the therapeutic potential of Tylophora indica"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8902-0888","authenticated-orcid":false,"given":"Dibyendu","family":"Halder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2162-6331","authenticated-orcid":false,"given":"Md Sabbir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3484-533X","authenticated-orcid":false,"given":"Than","family":"Sue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7919-6150","authenticated-orcid":false,"given":"Mohammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umme Mim Sad","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Atiquzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Khatun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Khairul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8953-8661","authenticated-orcid":false,"given":"Rabeya Bashree","family":"Keya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0177-2102","authenticated-orcid":false,"given":"Arif","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1297-5019","authenticated-orcid":false,"given":"Md Asaduzzaman","family":"Sikder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10082","key":"10.1016\/j.compbiomed.2025.110867_bib1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.4127","article-title":"The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis","volume":"229","author":"Janssen","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.compbiomed.2025.110867_bib3","first-page":"1","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.compbiomed.2025.110867_bib4","first-page":"CCRPM","article-title":"Idiopathic pulmonary fibrosis: diagnosis and clinical manifestations","volume":"9","author":"Nakamura","year":"2015","journal-title":"Clin. Med. Insights Circulatory, Respir. Pulm. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S2213-2600(16)30325-3","article-title":"The diagnosis of idiopathic pulmonary fibrosis: current and future approaches","volume":"5","author":"Martinez","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.compbiomed.2025.110867_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"Maher","year":"2021","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib7","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.compbiomed.2025.110867_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40266-016-0366-1","article-title":"Idiopathic pulmonary fibrosis and the elderly: diagnosis and management considerations","volume":"33","author":"Jo","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.compbiomed.2025.110867_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-019-1084-0","article-title":"Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry","volume":"20","author":"Fern\u00e1ndez-Fabrellas","year":"2019","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110867_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1164\/rccm.200602-163OC","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis","volume":"174","author":"Raghu","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.compbiomed.2025.110867_bib11","series-title":"The Age of Idiopathic Pulmonary Fibrosis","author":"Collard","year":"2010"},{"issue":"19","key":"10.1016\/j.compbiomed.2025.110867_bib12","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.compbiomed.2025.110867_bib13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.matbio.2018.01.023","article-title":"Biomarkers in idiopathic pulmonary fibrosis","volume":"68","author":"Drakopanagiotakis","year":"2018","journal-title":"Matrix Biol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110867_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13081","article-title":"A novel multikinase inhibitor SKLB\u2010YTH\u201060 ameliorates inflammation and fibrosis in bleomycin\u2010induced lung fibrosis mouse models","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"issue":"Supplement 1","key":"10.1016\/j.compbiomed.2025.110867_bib15","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1513\/AnnalsATS.201410-448MG","article-title":"Mechanisms of alveolar epithelial injury, repair, and fibrosis","volume":"12","author":"Chambers","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"148","key":"10.1016\/j.compbiomed.2025.110867_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0033-2018","article-title":"Matrix abnormalities in pulmonary fibrosis","volume":"27","author":"Upagupta","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.compbiomed.2025.110867_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12931-016-0343-6","article-title":"Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis","volume":"17","author":"Pardo","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.compbiomed.2025.110867_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib19","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.092134099","article-title":"Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans","volume":"99","author":"Zuo","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1164\/rccm.200504-644OC","article-title":"Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis","volume":"173","author":"Selman","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1164\/rccm.201001-0028OC","article-title":"Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing","volume":"182","author":"Garc\u00eda-de-Alba","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.compbiomed.2025.110867_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00408-017-9993-5","article-title":"Blood biomarkers in idiopathic pulmonary fibrosis","volume":"195","author":"Guiot","year":"2017","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/23120541.00074-2016","article-title":"MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis","volume":"3","author":"Bauer","year":"2017","journal-title":"ERJ Open Res"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1165\/rcmb.2015-0020TR","article-title":"Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis","volume":"53","author":"Craig","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110867_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/resp.14894","article-title":"Pre\u2010treatment MMP7 predicts progressive idiopathic pulmonary fibrosis in antifibrotic treated patients","volume":"30","author":"Li","year":"2025","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ceb.2009.06.006","article-title":"Matrix metalloproteinase proteomics: substrates, targets, and therapy","volume":"21","author":"Morrison","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1165\/ajrcmb.24.2.4096","article-title":"Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor\u2013like growth factor: a mitogen for lung fibroblasts","volume":"24","author":"Zhang","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110867_bib28","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0002-9440(10)64318-0","article-title":"Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium","volume":"162","author":"McGuire","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.compbiomed.2025.110867_bib29","series-title":"A clinical-stage Rnai Therapeutic Candidate for IPF Mediates Durable MMP7 Silencing in Nonhuman Primates and Human Lung Tissue","author":"Yuan","year":"2023"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073279","article-title":"Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis","volume":"8","author":"Nkyimbeng","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110867_bib31","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1371\/journal.pmed.0050093","article-title":"MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"5","author":"Rosas","year":"2008","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110867_bib32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.rmed.2015.06.003","article-title":"Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias","volume":"109","author":"Morais","year":"2015","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pccm.2024.04.003","article-title":"Biomarkers in idiopathic pulmonary fibrosis: current insight and future direction","volume":"2","author":"Zheng","year":"2024","journal-title":"Chinese Med. J. Pulm. Crit. care Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib34","article-title":"Comparative study of circulating MMP\u20107, CCL18, KL\u20106, SP\u2010A, and SP\u2010D as disease markers of idiopathic pulmonary fibrosis","volume":"2016","author":"Hamai","year":"2016","journal-title":"Dis. Markers"},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110867_bib35","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.201505-0862OC","article-title":"Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias","volume":"194","author":"White","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.compbiomed.2025.110867_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113714","article-title":"Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: medicinal chemistry perspectives","volume":"224","author":"Yue","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.110867_bib37","doi-asserted-by":"crossref","unstructured":"J.M. Samet, D. Coultas, G. Raghu, Idiopathic pulmonary fibrosis: tracking the true occurrence is challenging, Eur Respiratory Soc. 46 (3)(2015) 604-606.","DOI":"10.1183\/13993003.00958-2015"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1513\/pats.201112-055AW","article-title":"The genetic and environmental causes of pulmonary fibrosis","volume":"9","author":"Macneal","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"22","key":"10.1016\/j.compbiomed.2025.110867_bib39","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.compbiomed.2025.110867_bib40","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.compbiomed.2025.110867_bib41","first-page":"167","article-title":"Tylophorine: sources, properties, applications and biotechnological production","author":"Cyriac","year":"2020","journal-title":"Plant-derived Bioact. Prod. Prop. Ther. Appl."},{"key":"10.1016\/j.compbiomed.2025.110867_bib42","series-title":"Rapid Micropropagation of Tylophora indica","author":"Nema","year":"2007"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib43","first-page":"389","article-title":"Diverse pharmacological potentials of an indigenous climber Tylophora indica (Burm. F.) Merr.: a review","volume":"12","author":"Khanna","year":"2018","journal-title":"J. Pharm. Res."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110867_bib44","first-page":"1089","article-title":"Ethnobotanical study of medicinal plants used by traditional users in Villupuram district of Tamil Nadu, India","volume":"4","author":"Sankaranarayanan","year":"2010","journal-title":"J. Med. Plants Res."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib45","first-page":"408","article-title":"Traditional medicinal plants in seshachalam hills, Andhra Pradesh, India","volume":"3","author":"Reddy","year":"2009","journal-title":"J. Med. Plants Res."},{"key":"10.1016\/j.compbiomed.2025.110867_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113122","article-title":"Tylophora indica (Burm. f.) merr: an insight into phytochemistry and pharmacology","volume":"262","author":"Gururani","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.compbiomed.2025.110867_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","article-title":"The bleomycin model of pulmonary fibrosis","volume":"1627","author":"Liu","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib48","doi-asserted-by":"crossref","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","article-title":"Murine models of pulmonary fibrosis","volume":"294","author":"Moore","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.compbiomed.2025.110867_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1289\/ehp.7616119","article-title":"Pulmonary toxicity of bleomycin","volume":"16","author":"Adamson","year":"1976","journal-title":"Environ. Health Perspect."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib50","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/1097-0142(1967)20:5<891::AID-CNCR2820200550>3.0.CO;2-V","article-title":"Studies on bleomycin","volume":"20","author":"Umezawa","year":"1967","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/0471141755.ph0546s40","article-title":"Mouse models of bleomycin\u2010induced pulmonary fibrosis","volume":"40","author":"Walters","year":"2008","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110867_bib52","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0006-291X(77)80099-5","article-title":"The mechanism of the bleomycin-induced cleavage of DNA","volume":"77","author":"Lown","year":"1977","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib53","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1021\/cr980449z","article-title":"Nucleic acid recognition by metal complexes of bleomycin","volume":"99","author":"Claussen","year":"1999","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110867_bib54","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200505-717OC","article-title":"Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model","volume":"173","author":"Chaudhary","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib55","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1152\/jappl.1991.70.3.1300","article-title":"Changes of lung surfactant and pressure-volume curve in bleomycin-induced pulmonary fibrosis","volume":"70","author":"Osanai","year":"1991","journal-title":"J. Appl. Physiol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/00313029209063164","article-title":"Development of a bleomycin hamster model of subchronic lung fibrosis","volume":"24","author":"Zia","year":"1992","journal-title":"Pathology"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110867_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1440-1827.1995.tb03503.x","article-title":"Evolution of three patterns of intra\u2010alveolar fibrosis produced by bleomycin in rats","volume":"45","author":"Usuki","year":"1995","journal-title":"Pathol. Int."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib58","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/clpt.2009.293","article-title":"Deconstructing the drug development process: the new face of innovation","volume":"87","author":"Kaitin","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib59","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030917","article-title":"A comprehensive in silico exploration of pharmacological properties, bioactivities, molecular docking, and anticancer potential of vieloplain F from Xylopia vielana targeting B-Raf kinase","volume":"27","author":"Hassan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2025.110867_bib61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fmed.2018.00269","article-title":"Bleomycin revisited: a direct comparison of the intratracheal micro-spraying and the oropharyngeal aspiration routes of bleomycin administration in mice","volume":"5","author":"Barbayianni","year":"2018","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"15","key":"10.1016\/j.compbiomed.2025.110867_bib63","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS\u2010MODEL and the swiss\u2010Pdb viewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib64","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","article-title":"Imppat 2.0: an enhanced and expanded phytochemical atlas of Indian medicinal plants","volume":"8","author":"Vivek-Ananth","year":"2023","journal-title":"ACS Omega"},{"issue":"D1","key":"10.1016\/j.compbiomed.2025.110867_bib65","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.110867_bib66","doi-asserted-by":"crossref","first-page":"W315","DOI":"10.1093\/nar\/gkx337","article-title":"GASS-WEB: a web server for identifying enzyme active sites based on genetic algorithms","volume":"45","author":"Moraes","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib67","first-page":"1","article-title":"Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein","volume":"11","author":"Opo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2025.110867_bib68","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","author":"Dallakyan","year":"2015","journal-title":"Chem. Biol. methods Protoc"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib69","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s11030-022-10491-9","article-title":"Natural flavonoids effectively block the CD81 receptor of hepatocytes and inhibit HCV infection: a computational drug development approach","volume":"27","author":"Dey","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.compbiomed.2025.110867_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7111786","article-title":"Evaluation of melongosides as potential inhibitors of NS2B-NS3 activator-protease of dengue virus (Serotype 2) by using molecular docking and dynamics simulation approach","volume":"2022","author":"Biswas","year":"2022","journal-title":"J. Trop. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202100542","article-title":"Recent advances in the prediction of pharmacokinetics properties in drug design studies: a review","volume":"17","author":"Pantale\u00e3o","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.compbiomed.2025.110867_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib73","article-title":"Esculetin unveiled: decoding its anti\u2010tumor potential through molecular mechanisms\u2014A comprehensive review","volume":"7","author":"Rezoan Hossain","year":"2024","journal-title":"Cancer Rep"},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110867_bib74","doi-asserted-by":"crossref","first-page":"14556","DOI":"10.1002\/cam4.5984","article-title":"Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: a comprehensive review","volume":"12","author":"Sohel","year":"2023","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib75","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"V Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"January","key":"10.1016\/j.compbiomed.2025.110867_bib76","article-title":"Harnessing the therapeutic potential of Coccinia grandis phytochemicals in diabetes: a computational, DFT calculation and MMGBSA perspective on aldose reductase inhibition","volume":"46","author":"Ahmed","year":"2024","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.compbiomed.2025.110867_bib77","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.physchem.55.091602.094410","article-title":"Ab initio quantum chemical and mixed quantum mechanics\/molecular mechanics (QM\/MM) methods for studying enzymatic catalysis","volume":"56","author":"Friesner","year":"2005","journal-title":"Annu. Rev. Phys. Chem."},{"key":"10.1016\/j.compbiomed.2025.110867_bib78","series-title":"Gaussview, Version 6.0. 16","author":"Dennington","year":"2016"},{"key":"10.1016\/j.compbiomed.2025.110867_bib79","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B Condens. Matter."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110867_bib80","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1103\/PhysRevA.38.3098","article-title":"Density-functional exchange-energy approximation with correct asymptotic behavior","volume":"38","author":"Becke","year":"1988","journal-title":"Phys. Rev. A"},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110867_bib81","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1073\/pnas.76.6.2522","article-title":"Local density functional theory of atoms and molecules","volume":"76","author":"Parr","year":"1979","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.compbiomed.2025.110867_bib82","series-title":"Density-Functional Theory of Atoms and Molecules","first-page":"333","author":"Patterson","year":"1989"},{"issue":"22","key":"10.1016\/j.compbiomed.2025.110867_bib83","doi-asserted-by":"crossref","first-page":"8440","DOI":"10.1073\/pnas.83.22.8440","article-title":"Absolute electronegativity and hardness correlated with molecular orbital theory","volume":"83","author":"Pearson","year":"1986","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib84","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/molecules27020492","article-title":"Can Artemisia herba-alba be useful for managing COVID-19 and comorbidities?","volume":"27","author":"Hasan","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110867_bib85","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/pr9081449","article-title":"In vivo neuropharmacological potential of Gomphandra tetrandra (Wall.) Sleumer and in-silico study against \u03b2-amyloid precursor protein","volume":"9","author":"Rahman","year":"2021","journal-title":"Processes"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101884","article-title":"Identification of antidiabetic inhibitors from Allophylus villosus and Mycetia sinensis by targeting \u03b1-glucosidase and PPAR-\u03b3: In-vitro, in-vivo, and computational evidence","volume":"32","author":"Nur Kabidul Azam","year":"2024","journal-title":"Saudi Pharm. J."},{"issue":"9807","key":"10.1016\/j.compbiomed.2025.110867_bib87","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.compbiomed.2025.110867_bib88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/2050-6511-15-63","article-title":"The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation","volume":"15","author":"Loveman","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020251","article-title":"Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis","volume":"2","author":"Pardo","year":"2005","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib90","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acs.jmedchem.6b00935","article-title":"Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets","volume":"60","author":"Liu","year":"2017","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib91","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1183\/09031936.02.00022302","article-title":"Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF","volume":"20","author":"Henry","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib92","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","article-title":"Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.compbiomed.2025.110867_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1549277","article-title":"PI3K\/Akt in IPF: untangling fibrosis and charting therapies","volume":"16","author":"Bhatt","year":"2025","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110867_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.744","article-title":"Pulmonary fibrosis: pathogenesis and therapeutic strategies","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib95","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1681\/ASN.2016030354","article-title":"Matrix metalloproteinase-7 is a urinary biomarker and pathogenic mediator of kidney fibrosis","volume":"28","author":"Zhou","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.compbiomed.2025.110867_bib96","first-page":"21","article-title":"Matrix metalloproteinases-7 and kidney fibrosis","volume":"8","author":"Ke","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.compbiomed.2025.110867_bib97","volume":"vol. 2","author":"Vivean","year":"2015"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib98","doi-asserted-by":"crossref","first-page":"56","DOI":"10.18579\/jpcrkc\/2009\/8\/1\/79792","article-title":"Effect of methanolic extracts of Tylophora indica L. leaves on lipid profile in rats","volume":"8","author":"Basheeruddin","year":"2009","journal-title":"J. Pharm. Res."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110867_bib99","first-page":"172","article-title":"Tylophora indica in bronchial asthma (a controlled comparison with a standard anti-asthmatic drug)","volume":"71","author":"Thiruvengadam","year":"1978","journal-title":"J. Indian Med. Assoc."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib100","article-title":"Effect of hydroalcoholic extracts of Tylophora indica leaves in isoprenaline-induced myocardial damage in rat heart","volume":"9","author":"Asdaq","year":"2010","journal-title":"Iran. J. Pharmacol. Ther."},{"key":"10.1016\/j.compbiomed.2025.110867_bib101","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3923\/jpt.2006.490.492","article-title":"Anti-inflammatory activity of Tylophora indica in albino rats","volume":"1","author":"Raj","year":"2006","journal-title":"J. Pharmacol. Toxicol."},{"key":"10.1016\/j.compbiomed.2025.110867_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-016-2543-2","article-title":"Tissue remodelling in pulmonary fibrosis","volume":"367","author":"Knudsen","year":"2017","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154516","article-title":"Immune inflammation and disease progression in idiopathic pulmonary fibrosis","volume":"11","author":"Balestro","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020283","article-title":"Matrix metalloproteinase 7 expression and apical epithelial defects in Atp8b1 mutant mouse model of pulmonary fibrosis","volume":"12","author":"Westermann-Clark","year":"2022","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110867_bib105","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib106","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1093-3263(00)00084-X","article-title":"Theoretical hydrogen bonding parameters for drug design","volume":"19","author":"Gancia","year":"2001","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.compbiomed.2025.110867_bib107","unstructured":"Global Challenges - 2020 - Li - a Hydrophobic\u2010Interaction\u2010Based Mechanism Triggers Docking Between the SARS\u2010CoV\u20102 Spike And.Pdf.\u201d."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110867_bib108","article-title":"Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing","volume":"5","author":"Varma","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2025.110867_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202303557","article-title":"Amazon plant-derived compounds suppressing dengue NS5 protein: insights from computational drug development and network pharmacology approach","volume":"9","author":"Ahmed","year":"2024","journal-title":"ChemistrySelect"},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110867_bib110","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1021\/jm0109053","article-title":"Structural differences of matrix metalloproteinases with potential implications for inhibitor selectivity examined by the GRID\/CPCA approach","volume":"45","author":"Terp","year":"2002","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051076","article-title":"Structure and function of human matrix metalloproteinases","volume":"9","author":"Laronha","year":"2020","journal-title":"Cells"},{"issue":"March","key":"10.1016\/j.compbiomed.2025.110867_bib112","first-page":"1","article-title":"Identification of zinc-binding inhibitors of matrix Metalloproteinase-9 to prevent cancer through deep learning and molecular dynamics simulation approach","volume":"9","author":"Mathpal","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"15","key":"10.1016\/j.compbiomed.2025.110867_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512133","article-title":"Novel matrix Metalloproteinase-9 (MMP-9) inhibitors in cancer treatment","volume":"24","author":"Rashid","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib114","first-page":"298","article-title":"Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog","volume":"7","author":"Ahmad","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110867_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22255","article-title":"Biphenylsulfonamides as effective MMP-2 inhibitors with promising antileukemic efficacy: synthesis, in vitro biological evaluation, molecular docking, and MD simulation analysis","volume":"85","author":"Baidya","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110867_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071679","article-title":"Conformation-specific inhibitory Anti-MMP-7 monoclonal antibody sensitizes pancreatic ductal adenocarcinoma cells to chemotherapeutic cell kill","volume":"13","author":"Mohan","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib117","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bmc.2019.03.043","article-title":"Identification of highly potent and selective MMP2 inhibitors addressing the S1\u2032 subsite with D-proline-based compounds","volume":"27","author":"Lenci","year":"2019","journal-title":"Bioorganic Med. Chem."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700447","article-title":"Safety aspects of the use of quercetin as a dietary supplement","volume":"62","author":"Andres","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110867_bib119","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.bbamcr.2017.06.017","article-title":"Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent akt activation and Snail-independent ADAM9 expression pathways","volume":"1864","author":"Chang","year":"2017","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.compbiomed.2025.110867_bib120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2017.05.011","article-title":"Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01\/04 cells through transforming growth factor-\u03b22\/phosphoinositide 3-kinase\/Akt pathway","volume":"452","author":"Du","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110867_bib121","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1039\/C9FO00373H","article-title":"Quercetin inhibits kidney fibrosis and the epithelial to mesenchymal transition of the renal tubular system involving suppression of the sonic hedgehog signaling pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110867_bib122","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.dmpk.2020.08.001","article-title":"Suppressive effect of quercetin against bleomycin-induced epithelial-mesenchymal transition in alveolar epithelial cells","volume":"35","author":"Takano","year":"2020","journal-title":"Drug Metabol. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib123","first-page":"433","article-title":"The chemical examination of Tylophora asthmatica and isolation of the alkaloids tylophorine and tylophorinine","volume":"22","author":"Ratnagiriswaran","year":"1935","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib124","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2009.05.138","article-title":"Tylophorine arrests carcinoma cells at G1 phase by downregulating cyclin A2 expression","volume":"386","author":"Wu","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-12-82","article-title":"Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis","volume":"12","author":"Saraswati","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.compbiomed.2025.110867_bib126","series-title":"Tylophora indica (Burm. F.) Merrill: Medicinal Uses, Propagation, and Replenishment BT - Biotechnological Strategies for the Conservation of Medicinal and Ornamental Climbers","first-page":"239","author":"Shahzad","year":"2016"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib127","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0887-2333(99)00092-2","article-title":"Inhibition of dihydrofolate reductase and cell growth activity by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine: the in vitro cytotoxicity of these plant alkaloids and their potential as antimicrobial and anticancer agents","volume":"14","author":"Rao","year":"2000","journal-title":"Toxicol. Vitro"},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110867_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24122277","article-title":"Kaempferol: a key emphasis to its anticancer potential","volume":"24","author":"Imran","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1207\/s15327914nc5001_1","article-title":"Dietary flavonoids and cancer risk: evidence from human population studies","volume":"50","author":"Neuhouser","year":"2004","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.compbiomed.2025.110867_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111085","article-title":"Kaempferol mitigates sepsis-induced acute lung injury by modulating the SphK1\/S1P\/S1PR1\/MLC2 signaling pathway to restore the integrity of the pulmonary endothelial cell barrier","volume":"398","author":"Gao","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.compbiomed.2025.110867_bib131","article-title":"Exploring the molecular mechanism by which kaempferol attenuates sepsis-related acute respiratory distress syndrome based on network pharmacology and experimental verification","author":"Ding","year":"2024","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.compbiomed.2025.110867_bib132","article-title":"Modeling kaempferol as a potential pharmacological agent for COVID-19\/PF Co-Occurrence based on bioinformatics and system pharmacological tools","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib133","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0273-2300(90)90028-A","article-title":"The importance of pharmacokinetic and receptor studies in drug safety evaluation","volume":"11","author":"Eason","year":"1990","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"May","key":"10.1016\/j.compbiomed.2025.110867_bib134","first-page":"20","article-title":"M9 biopharmaceutics classification SystemBased biowaivers: guidance for industry","year":"2021","journal-title":"Publ. by ICH"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110867_bib135","first-page":"670","article-title":"Who guideline on biopharmaceutics classification system-based biowaivers","volume":"37","author":"Agency","year":"2023","journal-title":"WHO Drug Inf."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib136","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib137","doi-asserted-by":"crossref","DOI":"10.1186\/s42269-022-00869-y","article-title":"Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agents","volume":"46","author":"Abdullahi","year":"2022","journal-title":"Bull. Natl. Res. Cent."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib138","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-021-00288-2","article-title":"Pharmacokinetic predictions and docking studies of substituted aryl amine-based triazolopyrimidine designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH)","volume":"7","author":"Ibrahim","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib139","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yrtph.2011.05.013","article-title":"Efficacy of predictive modeling as a scientific criterion in dermal hazard identification for assignment of skin notations","volume":"61","author":"Chen","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.compbiomed.2025.110867_bib140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.compbiomed.2025.110867_bib141","series-title":"Systems Pharmacology in Small Molecular Drug Discovery","author":"Zhou","year":"2016"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7090296","article-title":"Contemporary strategies and current trends in designing antiviral drugs against dengue fever via targeting host-based approaches","volume":"7","author":"Ahammad","year":"2019","journal-title":"Microorganisms"},{"issue":"1\u20132","key":"10.1016\/j.compbiomed.2025.110867_bib143","first-page":"29","article-title":"The ames Salmonella\/microsome mutagenicity assay","volume":"455","author":"Mortelmans","year":"2000","journal-title":"Mutat. Res."},{"issue":"W1","key":"10.1016\/j.compbiomed.2025.110867_bib144","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.110867_bib145","series-title":"Safety and Efficacy of the Novel BRAF Inhibitor FORE8394 in Patients with Advanced Solid and CNS Tumors: Results from a Phase 1\/2a Study","author":"De La Fuente","year":"2023"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib146","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/md19050253","article-title":"Compounds identified from marine mangrove plant (Avicennia alba) as potential antiviral drug candidates against WDSV, an in-silico approach","volume":"19","author":"Aljahdali","year":"2021","journal-title":"Mar. Drugs"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib147","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jmgm.2010.12.005","article-title":"Exploring the conformational changes of the ATP binding site of gyrase B from Escherichia coli complexed with different established inhibitors by using molecular dynamics simulation: Protein\u2013Ligand interactions in the light of the alanine scanning and fre","volume":"29","author":"Sa\u00edz-Urra","year":"2011","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.compbiomed.2025.110867_bib148","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6237160","article-title":"Phytochemicals from selective plants have promising potential against SARS-CoV-2: investigation and corroboration through molecular docking, MD simulations, and quantum computations","volume":"2020","author":"Kousar","year":"2020","journal-title":"BioMed Res. Int."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib149","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1016\/j.arabjc.2020.08.004","article-title":"Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics","volume":"13","author":"Alamri","year":"2020","journal-title":"Arab. J. Chem."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jmv.24934","article-title":"Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds","volume":"90","author":"Elfiky","year":"2018","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib151","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5469258","article-title":"In silico identification and analysis of potentially bioactive antiviral phytochemicals against SARS\u2010CoV\u20102: a molecular docking and dynamics simulation approach","volume":"2023","author":"Halder","year":"2023","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib152","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1021\/ar00029a005","article-title":"Absolute hardness: unifying concept for identifying shells and subshells in nuclei, atoms, molecules, and metallic clusters","volume":"26","author":"Parr","year":"1993","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110867_bib153","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phymed.2008.12.018","article-title":"Synergy research: approaching a new generation of phytopharmaceuticals","volume":"16","author":"Wagner","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.compbiomed.2025.110867_bib154","first-page":"197","article-title":"An overview of ethnobotanical studies on plants used for the treatment of malaria","volume":"187","author":"Willcox","year":"2004","journal-title":"Tradit. Med. Plants Malar."},{"issue":"May 2024","key":"10.1016\/j.compbiomed.2025.110867_bib155","first-page":"2014","volume":"2013","author":"Organization","year":"2025","journal-title":"Draft global traditional medicine strategy (2025 \u2013 2034)"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110867_bib156","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1078\/0944-7113-00055","article-title":"Inhibition of cellular immune responses by Tylophora indica in experimental models","volume":"8","author":"Ganguly","year":"2001","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110867_bib157","doi-asserted-by":"crossref","first-page":"9","DOI":"10.54203\/scil.2025.wvj2","article-title":"Synergistic effects of phenanthroindolizidine alkaloids from Tylophora indica against ascaridia galli: phytochemical characterization and in vitro evaluation","volume":"15","author":"Yadagiri","year":"2025","journal-title":"World's Vet. J. (WVJ)"},{"issue":"November 2024","key":"10.1016\/j.compbiomed.2025.110867_bib158","first-page":"11","volume":"2","author":"Tessema","year":"2025","journal-title":"Silico Stud. Support Nat. Product. Res."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110867_bib159","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.2174\/138920112800958940","article-title":"In silico search for drug targets of natural compounds","volume":"13","author":"Yao","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"45","key":"10.1016\/j.compbiomed.2025.110867_bib160","doi-asserted-by":"crossref","first-page":"31578","DOI":"10.1039\/D3RA06831E","article-title":"Challenges in natural product-based drug discovery assisted with in silico-based methods","volume":"13","author":"Simoben","year":"2023","journal-title":"RSC Adv."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525012181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525012181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:11:39Z","timestamp":1779509499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525012181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":160,"alternative-id":["S0010482525012181"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110867","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting MMP-7 in idiopathic pulmonary fibrosis: An integrative in vivo and in silico evaluation of the therapeutic potential of Tylophora indica","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110867"}}